FDA Seems to Back Pill to Help Prevent HIV

<p>WEDNESDAY, May 9 (HealthDay News) U.S. Food and Drug
Administration advisers will accommodate Thursday to confirm either to endorse
the use of a drug Truvada as a means to assistance forestall HIV infection in
people during high risk.
Those people competence embody rarely intimately active happy or bisexual
men, or a partners of people already putrescent with HIV, a pathogen that
causes AIDS.
A news expelled by a FDA this week forward of Thursdays meeting
suggests that experts do trust a drug is stable and effective for this
use.
There are intensity drawbacks to regulating a remedy in this way,
however. Truvada that combines dual HIV-fighting drugs, tenofovir
(Viread) and emtricitabine (Emtriva) is unequivocally dear and competence cause
side effects. And nonetheless doctors can already allot it to people
trying to equivocate HIV infection, critics contend its too early to officially
allow it to be promoted for that use.
On a other hand, those who support selling a drug a...